Accueil > Les Laboratoires > Hôpital Bicêtre AP-HP > Publications de l’équipe
Années 2017-2020
>Diversity of mucoid to non-mucoid switch among carbapenemase-producing Klebsiella pneumoniae. Chiarelli A, Cabanel N, Rosinski-Chupin I, Zongo PD, Naas T, Bonnin RA, Glaser P. BMC Microbiol. 2020 Oct 2720(1):325.
>Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial. Bassetti M, Echols R, Matsunaga Y, Ariyasu M, Doi Y, Ferrer R, Lodise TP, Naas T, Niki Y, Paterson DL, Portsmouth S, Torre-Cisneros J, Toyoizumi K, Wunderink RG, Nagata TD. Lancet Infect Dis. 2020 Oct 12:S1473-3099(20)30796-9.
>Carbapenemase-producing Enterobacterales outbreak: Another dark side of COVID-19. Farfour E, Lecuru M, Dortet L, Le Guen M, Cerf C, Karnycheff F, Bonnin RA, Vasse M, Lesprit P SARS-CoV-2 Hospital Foch study group.Am J Infect Control. 2020 Oct 2:S0196-6553(20)30895-6.
>A Lateral Flow Immunoassay for the Rapid Identification of CTX-M-Producing Enterobacterales from Culture Plates and Positive Blood Cultures. Bernabeu S, Ratnam KC, Boutal H, Gonzalez C, Vogel A, Devilliers K, Plaisance M, Oueslati S, Malhotra-Kumar S, Dortet L, Fortineau N, Simon S, Volland H, Naas T.Diagnostics (Basel). 2020 Sep 2810(10):764.
>Carbapenemase -producing Pseudomonas aeruginosa isolates from Turkey: first report of P. aeruginosa high-risk clones with VIM-5- and IMP-7-type carbapenemases in a tertiary hospital. Çekin ZK, Dabos L, Malkoço?lu G, Fortineau N, Bayraktar B, Iorga BI, Naas T, Akta? E.Diagn Microbiol Infect Dis. 2020 Aug 1299(1):115174.
>Compassionate Use of Cefiderocol to Treat a Case of Prosthetic Joint Infection Due to Extensively Drug-Resistant Enterobacter hormaechei. Siméon S, Dortet L, Bouchand F, Roux AL, Bonnin RA, Duran C, Decousser JW, Bessis S, Davido B, Sorriaux G, Dinh A.Microorganisms. 2020 Aug 138(8):1236.
>Detection of Colistin Resistance in Salmonella enterica Using MALDIxin Test on the Routine MALDI Biotyper Sirius Mass Spectrometer. Dortet L, Bonnin RA, Le Hello S, Fabre L, Bonnet R, Kostrzewa M, Filloux A, Larrouy-Maumus G.Front Microbiol. 2020 Jun 311:1141.
>A single Proteus mirabilis lineage from human and animal sources: a hidden reservoir of OXA-23 or OXA-58 carbapenemases in Enterobacterales. Bonnin RA, Girlich D, Jousset AB, Gauthier L, Cuzon G, Bogaerts P, Haenni M, Madec JY, Couvé-Deacon E, Barraud O, Fortineau N, Glaser P, Glupczynski Y, Dortet L, Naas T.Sci Rep. 2020 Jun 810(1):9160.
>Cross-border spread of bla (NDM-1)- and bla (OXA-48)-positive Klebsiella pneumoniae: a European collaborative analysis of whole genome sequencing and epidemiological data, 2014 to 2019. Ludden C, Lötsch F, Alm E, Kumar N, Johansson K, Albiger B, Huang TD, Denis O, Hammerum AM, Hasman H, Jalava J, Räisänen K, Dortet L, Jousset AB, Gatermann S, Haller S, Cormican M, Brennan W, Del Grosso M, Monaco M, Schouls L, Samuelsen Ø, Pirš M, Cerar T, Oteo-Iglesias J, Pérez-Vázquez M, Sjöström K, Edquist P, Hopkins KL, Struelens MJ, Palm D, Monnet DL, Kohlenberg A.Euro Surveill. 2020 May25(20):2000627.
>Performance of commercial methods for linezolid susceptibility testing of Enterococcus faecium and Enterococcus faecalis. Dejoies L, Boukthir S, Péan de Ponfilly G, Le Guen R, Zouari A, Potrel S, Collet A, Auger G, Jacquier H, Fihman V, Dortet L, Cattoir V.J Antimicrob Chemother. 2020 Sep 175(9):2587-2593.
>Emergence of New Non-Clonal Group 258 High-Risk Clones among Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae Isolates, France. Bonnin RA, Jousset AB, Chiarelli A, Emeraud C, Glaser P, Naas T, Dortet L.Emerg Infect Dis. 2020 Jun26(6):1212-1220.
>Evaluation of the Novodiag CarbaR+, a Novel Integrated Sample to Result Platform for the Multiplex Qualitative Detection of Carbapenem and Colistin Resistance Markers. Girlich D, Bogaerts P, Bouchahrouf W, Bernabeu S, Langlois I, Begasse C, Arangia N, Dortet L, Huang TD, Glupczynski Y, Naas T.Microb Drug Resist. 2020 May 19.
>NMR Characterization of the Influence of Zinc(II) Ions on the Structural and Dynamic Behavior of the New Delhi Metallo-β-Lactamase-1 and on the Binding with Flavonols as Inhibitors. Rivière G, Oueslati S, Gayral M, Créchet JB, Nhiri N, Jacquet E, Cintrat JC, Giraud F, van Heijenoort C, Lescop E, Pethe S, Iorga BI, Naas T, Guittet E, Morellet N.ACS Omega. 2020 Apr 285(18):10466-10480.
>Concomitant carriage of KPC-producing and non-KPC-producing Klebsiella pneumoniae ST512 within a single patient. Jousset AB, Bonnin RA, Takissian J, Girlich D, Mihaila L, Cabanel N, Dortet L, Glaser P, Naas T.J Antimicrob Chemother. 2020 Aug 175(8):2087-2092.
>Screening of OXA-244 producers, a difficult-to-detect and emerging OXA-48 variant? Emeraud C, Biez L, Girlich D, Jousset AB, Naas T, Bonnin RA, Dortet L.J Antimicrob Chemother. 2020 Aug 175(8):2120-2123.
>Substrate Specificity of OXA-48 after β5-β6 Loop Replacement. Dabos L, Zavala A, Bonnin RA, Beckstein O, Retailleau P, Iorga BI, Naas T.ACS Infect Dis. 2020 May 86(5):1032-1043.
>Genetics of Acquired Antibiotic Resistance Genes in Proteus spp. Girlich D, Bonnin RA, Dortet L, Naas T.Front Microbiol. 2020 Feb 2111:256.
>Role of Arginine 214 in the Substrate Specificity of OXA-48. Oueslati S, Retailleau P, Marchini L, Berthault C, Dortet L, Bonnin RA, Iorga BI, Naas T.Antimicrob Agents Chemother. 2020 Apr 2164(5):e02329-19.
>MCR-8 mediated colistin resistance in a carbapenem-resistant Klebsiella pneumoniae isolated from a repatriated patient from Morocco. Bonnin RA, Bernabeu S, Jaureguy F, Naas T, Dortet L.Int J Antimicrob Agents. 2020 Apr55(4):105920.
>Evaluation of the Revogene Carba C Assay for Detection and Differentiation of Carbapenemase-Producing Gram-Negative Bacteria. Girlich D, Laguide M, Dortet L, Naas T.J Clin Microbiol. 2020 Mar 2558(4):e01927-19.
>Stepwise evolution and convergent recombination underlie the global dissemination of carbapenemase-producing Escherichia coli. Patiño-Navarrete R, Rosinski-Chupin I, Cabanel N, Gauthier L, Takissian J, Madec JY, Hamze M, Bonnin RA, Naas T, Glaser P.Genome Med. 2020 Jan 2012(1):10.
>First Occurrence of the OXA-198 Carbapenemase in Enterobacterales. Bonnin RA, Jousset AB, Gauthier L, Emeraud C, Girlich D, Sauvadet A, Cotellon G, Jové T, Dortet L, Naas T.Antimicrob Agents Chemother. 2020 Mar 2464(4):e01471-19.
>Biochemical and Structural Characterization of OXA-405, an OXA-48 Variant with Extended-Spectrum β-Lactamase Activity. Oueslati S, Retailleau P, Marchini L, Dortet L, Bonnin RA, Iorga BI, Naas T.Microorganisms. 2019 Dec 218(1):24.
>Different phenotypic expression of KPC β-lactamase variants and challenges in their detection. Oueslati S, Tlili L, Exilie C, Bernabeu S, Iorga B, Bonnin RA, Dortet L, Naas T.J Antimicrob Chemother. 2020 Mar 175(3):769-771.
>Phylogeny, Resistome, and Virulome of Escherichia coli Causing Biliary Tract Infections. Rodríguez-Villodres Á, Bonnin RA, Ortiz de la Rosa JM, Álvarez-Marín R, Naas T, Aznar J, Pachón J, Lepe JA, Smani Y.J Clin Med. 2019 Dec 28(12):2118.
>LMB-1 producing Citrobacter freundii from Argentina, a novel player in the field of MBLs. Dabos L, Rodriguez CH, Nastro M, Dortet L, Bonnin RA, Famiglietti A, Iorga BI, Vay C, Naas T.Int J Antimicrob Agents. 2020 Feb55(2):105857.
>Evaluation of the BD MAX Check-Points CPO Assay for the Detection of Carbapenemase Producers Directly from Rectal Swabs. Girlich D, Oueslati S, Bernabeu S, Langlois I, Begasse C, Arangia N, Creton E, Cotellon G, Sauvadet A, Dortet L, Fortineau N, Naas T.J Mol Diagn. 2020 Feb22(2):294-300.
>Rapid Carbapenemase Detection With Xpert Carba-R V2 Directly On Positive Blood Vials. Cointe A, Walewski V, Hobson CA, Doit C, Bidet P, Dortet L, Bonacorsi S, Birgy A.Infect Drug Resist. 2019 Oct 2312:3311-3316.
>Improvement of the Immunochromatographic NG-Test Carba 5 Assay for the Detection of IMP Variants Previously Undetected. Volland H, Girlich D, Laguide M, Gonzalez C, Paris V, Laroche M, Oueslati S, Dortet L, Simon S, Naas T.Antimicrob Agents Chemother. 2019 Dec 2064(1):e01940-19.
>Successful use of culture and enrichment for the detection of OXA-181-producing Escherichia coli from rectal swab samples falsely categorized as negative by Xpert® Carba-R. Girlich D, Ouzani S, Langlois I, Begasse C, Arangia N, Fortineau N, Naas T, Dortet L.Diagn Microbiol Infect Dis. 2020 Jan96(1):114909.
>A 2.5-years within-patient evolution of a Pseudomonas aeruginosa with in vivo acquisition of ceftolozane-tazobactam and ceftazidime-avibactam resistance upon treatment. Boulant T, Jousset AB, Bonnin RA, Barrail-Tran A, Borgel A, Oueslati S, Naas T, Dortet L.Antimicrob Agents Chemother. 2019 Oct 2163(12):e01637-19.
>Prospective evaluation of the Amplidiag® CarbaR+VRE assay for direct screening of carbapenemase producing gram-negative bacilli from rectal swabs. Nadji S, Gaillot O, Hallaert C, Messaadi S, Loukili N, Naas T, Lemaître N.Diagn Microbiol Infect Dis. 2019 Dec95(4):114890.
>Extended-spectrum resistance to β-lactams/β-lactamase inhibitors (ESRI) evolved from low-level resistant Escherichia coli. Rodríguez-Villodres Á, Gil-Marqués ML, Álvarez-Marín R, Bonnin RA, Pachón-Ibáñez ME, Aguilar-Guisado M, Naas T, Aznar J, Pachón J, Lepe JA, Smani Y.J Antimicrob Chemother. 2020 Jan 175(1):77-85.
>Detection of Colistin Resistance in Escherichia coli by Use of the MALDI Biotyper Sirius Mass Spectrometry System. Furniss RCD, Dortet L, Bolland W, Drews O, Sparbier K, Bonnin RA, Filloux A, Kostrzewa M, Mavridou DAI, Larrouy-Maumus G.J Clin Microbiol. 2019 Nov 2257(12):e01427-19.
>Optimization of the MALDIxin test for the rapid identification of colistin resistance in Klebsiella pneumoniae using MALDI-TOF MS. Dortet L, Broda A, Bernabeu S, Glupczynski Y, Bogaerts P, Bonnin R, Naas T, Filloux A, Larrouy-Maumus G.J Antimicrob Chemother. 2020 Jan 175(1):110-116.
>Evaluation of the Immunochromatographic NG-Test Carba 5 for Rapid Identification of Carbapenemase in Nonfermenters. Potron A, Fournier D, Emeraud C, Triponney P, Plésiat P, Naas T, Dortet L.Antimicrob Agents Chemother. 2019 Aug 2363(9):e00968-19.
>ISAba1-dependent overexpression of eptA in clinical strains of Acinetobacter baumannii resistant to colistin. Potron A, Vuillemenot JB, Puja H, Triponney P, Bour M, Valot B, Amara M, Cavalié L, Bernard C, Parmeland L, Reibel F, Larrouy-Maumus G, Dortet L, Bonnin RA, Plésiat P.J Antimicrob Chemother. 2019 Sep 174(9):2544-2550.
>Escherichia coli ST410 among humans and the environment in Southeast Asia. Nadimpalli ML, de Lauzanne A, Phe T, Borand L, Jacobs J, Fabre L, Naas T, Le Hello S, Stegger M.Int J Antimicrob Agents. 2019 Aug54(2):228-232.
>CHROMagar™ ESBL/mSuperCARBA bi-plate medium for detection of ESBL- and carbapenemase-producing Enterobacteriaceae from spiked stools. Girlich D, Grosperrin V, Naas T, Dortet L.Diagn Microbiol Infect Dis. 2019 Oct95(2):107-112.
>Unravelling ceftazidime/avibactam resistance of KPC-28, a KPC-2 variant lacking carbapenemase activity. Oueslati S, Iorga BI, Tlili L, Exilie C, Zavala A, Dortet L, Jousset AB, Bernabeu S, Bonnin RA, Naas T.J Antimicrob Chemother. 2019 Aug 174(8):2239-2246.
>SME-4-producing Serratia marcescens from Argentina belonging to clade 2 of the S. marcescens phylogeny. Dabos L, Patiño-Navarrete R, Nastro M, Famiglietti A, Glaser P, Rodriguez CH, Naas T.J Antimicrob Chemother. 2019 Jul 174(7):1836-1841.
>Aztreonam plus Clavulanate, Tazobactam, or Avibactam for Treatment of Infections Caused by Metallo-β-Lactamase-Producing Gram-Negative Bacteria. Emeraud C, Escaut L, Boucly A, Fortineau N, Bonnin RA, Naas T, Dortet L.Antimicrob Agents Chemother. 2019 Apr 2563(5):e00010-19.
>Development and Multicentric Validation of a Lateral Flow Immunoassay for Rapid Detection of MCR-1-Producing Enterobacteriaceae. Volland H, Dortet L, Bernabeu S, Boutal H, Haenni M, Madec JY, Robin F, Beyrouthy R, Naas T, Simon S.J Clin Microbiol. 2019 Apr 2657(5):e01454-18.
>NG-Test Carba 5 for Rapid Detection of Carbapenemase-Producing Enterobacterales from Positive Blood Cultures. Takissian J, Bonnin RA, Naas T, Dortet L.Antimicrob Agents Chemother. 2019 Apr 2563(5):e00011-19.
>Genetic, Biochemical, and Structural Characterization of CMY-136 β-Lactamase, a Peculiar CMY-2 Variant. Zavala A, Retailleau P, Elisée E, Iorga BI, Naas T.ACS Infect Dis. 2019 Apr 125(4):528-538.
>False-Positive Carbapenem-Hydrolyzing Confirmatory Tests Due to ACT-28, a Chromosomally Encoded AmpC with Weak Carbapenemase Activity from Enterobacter kobei. Jousset AB, Oueslati S, Bernabeu S, Takissian J, Creton E, Vogel A, Sauvadet A, Cotellon G, Gauthier L, Bonnin RA, Dortet L, Naas T.Antimicrob Agents Chemother. 2019 Apr 2563(5):e02388-18.
>The challenges of designing a benchmark strategy for bioinformatics pipelines in the identification of antimicrobial resistance determinants using next generation sequencing technologies. Angers-Loustau A, Petrillo M, Bengtsson-Palme J, Berendonk T, Blais B, Chan KG, Coque TM, Hammer P, Heß S, Kagkli DM, Krumbiegel C, Lanza VF, Madec JY, Naas T, O'Grady J, Paracchini V, Rossen JWA, Ruppé E, Vamathevan J, Venturi V, Van den Eede G.F1000Res. 2018 Apr 137:ISCB Comm J-459.
>Meat and Fish as Sources of Extended-Spectrum β-Lactamase-Producing Escherichia coli, Cambodia. Nadimpalli M, Vuthy Y, de Lauzanne A, Fabre L, Criscuolo A, Gouali M, Huynh BT, Naas T, Phe T, Borand L, Jacobs J, Kerléguer A, Piola P, Guillemot D, Le Hello S, Delarocque-Astagneau E BIRDY study group.Emerg Infect Dis. 2019 Jan.
>Transcriptional Landscape of a bla (KPC-2) Plasmid and Response to Imipenem Exposure in Escherichia coli TOP10. Jousset AB, Rosinski-Chupin I, Takissian J, Glaser P, Bonnin RA, Naas T.Front Microbiol. 2018 Dec 39:2929.
>Evaluation of the Amplidiag CarbaR+MCR Kit for Accurate Detection of Carbapenemase-Producing and Colistin-Resistant Bacteria. Girlich D, Bernabeu S, Grosperrin V, Langlois I, Begasse C, Arangia N, Creton E, Cotellon G, Sauvadet A, Dortet L, Naas T.J Clin Microbiol. 2019 Feb 2757(3):e01800-18.
>Occurrence of carbapenemase-producing Enterobacteriaceae in Togo, West Africa. Dossim S, Bonnin RA, Salou M, Tanga K, Godonou V, Dagnra AY, Prince David M, Naas T, Dortet L.Int J Antimicrob Agents. 2019 Apr53(4):530-532
>Carbapenemase-producing Acinetobacter spp. from environmental sources in a hospital in French Polynesia. Bonnin RA, Levy M, Cuzon G, Dortet L, Naas T.J Glob Antimicrob Resist. 2019 Mar16:81-82.
>Rapid detection of colistin resistance in Acinetobacter baumannii using MALDI-TOF-based lipidomics on intact bacteria. Dortet L, Potron A, Bonnin RA, Plesiat P, Naas T, Filloux A, Larrouy-Maumus G.Sci Rep. 2018 Nov 158(1):16910.
>Higher Prevalence of PldA, a Pseudomonas aeruginosa Trans-Kingdom H2-Type VI Secretion System Effector, in Clinical Isolates Responsible for Acute Infections and in Multidrug Resistant Strains. Boulant T, Boudehen YM, Filloux A, Plesiat P, Naas T, Dortet L.Front Microbiol. 2018 Oct 299:2578.
>Development and validation of a multiplex polymerase chain reaction assay for detection of the five families of plasmid-encoded colistin resistance. Jousset AB, Bernabeu S, Bonnin RA, Creton E, Cotellon G, Sauvadet A, Naas T, Dortet L.Int J Antimicrob Agents. 2019 Mar53(3):302-309.
>Comparison of the Superpolymyxin and ChromID Colistin R Screening Media for the Detection of Colistin-Resistant Enterobacteriaceae from Spiked Rectal Swabs. Girlich D, Naas T, Dortet L.Antimicrob Agents Chemother. 2018 Dec 2163(1):e01618-18.
>Molecular characterization of plasmid-encoded Tripoli MBL 1 (TMB-1) in Enterobacteriaceae. Gauthier L, Dortet L, Jousset AB, Mihaila L, Golse N, Naas T, Bonnin RA.J Antimicrob Chemother. 2019 Jan 174(1):42-47.
>Evaluation of the NG-Test CARBA 5 multiplex immunochromatographic assay for the detection of KPC, OXA-48-like, NDM, VIM and IMP carbapenemases. Hopkins KL, Meunier D, Naas T, Volland H, Woodford N.J Antimicrob Chemother. 2018 Dec 173(12):3523-3526.
>Rapid detection and discrimination of chromosome- and MCR-plasmid-mediated resistance to polymyxins by MALDI-TOF MS in Escherichia coli: the MALDIxin test. Dortet L, Bonnin RA, Pennisi I, Gauthier L, Jousset AB, Dabos L, Furniss RCD, Mavridou DAI, Bogaerts P, Glupczynski Y, Potron A, Plesiat P, Beyrouthy R, Robin F, Bonnet R, Naas T, Filloux A, Larrouy-Maumus G.J Antimicrob Chemother. 2018 Dec 173(12):3359-3367.
>Novel Enterobacter Lineage as Leading Cause of Nosocomial Outbreak Involving Carbapenemase-Producing Strains. Beyrouthy R, Barets M, Marion E, Dananché C, Dauwalder O, Robin F, Gauthier L, Jousset A, Dortet L, Guérin F, Bénet T, Cassier P, Vanhems P, Bonnet R.Emerg Infect Dis. 2018 Aug24(8):1505-1515.
>Evaluation of the CRE and ESBL ELITe MGB® kits for the accurate detection of carbapenemase- or CTX-M-producing bacteria. Girlich D, Bernabeu S, Fortineau N, Dortet L, Naas T.Diagn Microbiol Infect Dis. 2018 Sep92(1):1-7.
>Within-a-Day Detection and Rapid Characterization of Carbapenemase by Use of a New Carbapenem Inactivation Method-Based Test, CIMplus. Caméléna F, Cointe A, Mathy V, Hobson C, Doit C, Bercot B, Decré D, Podglajen I, Dortet L, Monjault A, Bidet P, Bonacorsi S, Birgy A.J Clin Microbiol. 2018 Aug 2756(9):e00137-18.
>MALDI-TOF for the rapid detection of carbapenemase-producing Enterobacteriaceae: comparison of the commercialized MBT STAR®-Carba IVD Kit with two in-house MALDI-TOF techniques and the RAPIDEC® CARBA NP. Dortet L, Tandé D, de Briel D, Bernabeu S, Lasserre C, Gregorowicz G, Jousset AB, Naas T.J Antimicrob Chemother. 2018 Sep 173(9):2352-2359.
>Diversity of Carbapenemase-Producing Escherichia coli Isolates in France in 2012-2013. Gauthier L, Dortet L, Cotellon G, Creton E, Cuzon G, Ponties V, Bonnin RA, Naas T.Antimicrob Agents Chemother. 2018 Jul 2762(8):e00266-18.
>Proposing Kluyvera georgiana as the Origin of the Plasmid-Mediated Resistance Gene fosA4. Rodriguez MM, Ghiglione B, Power P, Naas T, Gutkind G.Antimicrob Agents Chemother. 2018 Jul 2762(8):e00710-18.
>Genetic and Biochemical Characterization of OXA-519, a Novel OXA-48-Like β-Lactamase. Dabos L, Bogaerts P, Bonnin RA, Zavala A, Sacré P, Iorga BI, Huang DT, Glupczynski Y, Naas T.Antimicrob Agents Chemother. 2018 Jul 2762(8):e00469-18.
>Whole-genome sequencing of NDM-1-producing ST85 Acinetobacter baumannii isolates from Tunisia. Jaidane N, Naas T, Oueslati S, Bernabeu S, Boujaafar N, Bouallegue O, Bonnin RA.Int J Antimicrob Agents. 2018 Dec52(6):916-921.
>Outbreak of IMI-1 carbapenemase-producing colistin-resistant Enterobacter cloacae on the French island of Mayotte (Indian Ocean). Miltgen G, Bonnin RA, Avril C, Benoit-Cattin T, Martak D, Leclaire A, Traversier N, Roquebert B, Jaffar-Bandjee MC, Lugagne N, Filleul L, Subiros M, de Montera AM, Cholley P, Thouverez M, Dortet L, Bertrand X, Naas T, Hocquet D, Belmonte O.Int J Antimicrob Agents. 2018 Sep52(3):416-420.
>A 4.5-Year Within-Patient Evolution of a Colistin-Resistant Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae Sequence Type 258. Jousset AB, Bonnin RA, Rosinski-Chupin I, Girlich D, Cuzon G, Cabanel N, Frech H, Farfour E, Dortet L, Glaser P, Naas T.Clin Infect Dis. 2018 Oct 1567(9):1388-1394.
>Molecular Characterization of OXA-198 Carbapenemase-Producing Pseudomonas aeruginosa Clinical Isolates. Bonnin RA, Bogaerts P, Girlich D, Huang TD, Dortet L, Glupczynski Y, Naas T.Antimicrob Agents Chemother. 2018 May 2562(6):e02496-17.
>Evaluation of the Carbapenem Detection Set™ for the detection and characterization of carbapenemase-producing Enterobacteriaceae. Dortet L, Bernabeu S, Gonzalez C, Naas T.Diagn Microbiol Infect Dis. 2018 Jul91(3):220-225.
>Integrase-Mediated Recombination of the bel-1 Gene Cassette Encoding the Extended-Spectrum β-Lactamase BEL-1. Bouheraoua N, Poirel L, Bourreau B, Bonnin R, Laroche L, Naas T, Nordmann P.Antimicrob Agents Chemother. 2018 Apr 2662(5):e00030-18.
>Complete Sequence of the IncA/C(1) Plasmid pCf587 Carrying bla(PER-2) from Citrobacter freundii. Ruggiero M, Girlich D, Dabos L, Power P, Naas T, Gutkind G.Antimicrob Agents Chemother. 2018 Apr 2662(5):e00006-18.
>Pore-forming activity of the Pseudomonas aeruginosa type III secretion system translocon alters the host epigenome. Dortet L, Lombardi C, Cretin F, Dessen A, Filloux A.Nat Microbiol. 2018 Mar3(3):378-386.
>A multiplex lateral flow immunoassay for the rapid identification of NDM-, KPC-, IMP- and VIM-type and OXA-48-like carbapenemase-producing Enterobacteriaceae. Boutal H, Vogel A, Bernabeu S, Devilliers K, Creton E, Cotellon G, Plaisance M, Oueslati S, Dortet L, Jousset A, Simon S, Naas T, Volland H.J Antimicrob Chemother. 2018 Apr 173(4):909-915.
>Evaluation of the rapid carbapenem inactivation method (rCIM): a phenotypic screening test for carbapenemase-producing Enterobacteriaceae. Muntean MM, Muntean AA, Gauthier L, Creton E, Cotellon G, Popa MI, Bonnin RA, Naas T.J Antimicrob Chemother. 2018 Apr 173(4):900-908.
>Evaluation of the Amplidiag CarbaR+VRE Kit for Accurate Detection of Carbapenemase-Producing Bacteria. Oueslati S, Girlich D, Dortet L, Naas T.J Clin Microbiol. 2018 Feb 2256(3):e01092-17.
>Analysis of OXA-204 carbapenemase-producing Enterobacteriaceae reveals possible endoscopy-associated transmission, France, 2012 to 2014. Potron A, Bernabeu S, Cuzon G, Pontiès V, Blanchard H, Seringe E, Naas T, Nordmann P, Dortet L.Euro Surveill. 2017 Dec22(49):17-00048.
>Genomic Insights into Colistin-Resistant Klebsiella pneumoniae from a Tunisian Teaching Hospital. Jaidane N, Bonnin RA, Mansour W, Girlich D, Creton E, Cotellon G, Chaouch C, Boujaafar N, Bouallegue O, Naas T.Antimicrob Agents Chemother. 2018 Jan 2562(2):e01601-17.
>Genomic analysis of in vivo acquired resistance to colistin and rifampicin in Acinetobacter baumannii. Jaidane N, Naas T, Mansour W, Radhia BB, Jerbi S, Boujaafar N, Bouallegue O, Bonnin RA.Int J Antimicrob Agents. 2018 Feb51(2):266-269.
>Long-lasting successful dissemination of resistance to oxazolidinones in MDR Staphylococcus epidermidis clinical isolates in a tertiary care hospital in France. Dortet L, Glaser P, Kassis-Chikhani N, Girlich D, Ichai P, Boudon M, Samuel D, Creton E, Imanci D, Bonnin R, Fortineau N, Naas T.J Antimicrob Chemother. 2018 Jan 173(1):41-51.
>Dissemination and genetic support of broad-spectrum beta-lactam-resistant Escherichia coli strain isolated from two Tunisian hospitals during 2004-2012. Ayari K, Bourouis A, Chihi H, Mahrouki S, Naas T, Belhadj O.Afr Health Sci. 2017 Jun17(2):346-355.
>CTX-M-15-Producing Shewanella Species Clinical Isolate Expressing OXA-535, a Chromosome-Encoded OXA-48 Variant, Putative Progenitor of the Plasmid-Encoded OXA-436. Jousset AB, Dabos L, Bonnin RA, Girlich D, Potron A, Cabanel N, Dortet L, Glaser P, Naas T.Antimicrob Agents Chemother. 2017 Dec 2162(1):e01879-17.
>OXA-427, a new plasmid-borne carbapenem-hydrolysing class D β-lactamase in Enterobacteriaceae. Bogaerts P, Naas T, Saegeman V, Bonnin RA, Schuermans A, Evrard S, Bouchahrouf W, Jove T, Tande D, de Bolle X, Huang TD, Dortet L, Glupczynski Y.J Antimicrob Chemother. 2017 Sep 172(9):2469-2477.
>Multicentre evaluation of the BYG Carba v2.0 test, a simplified electrochemical assay for the rapid laboratory detection of carbapenemase-producing Enterobacteriaceae. Bogaerts P, Oueslati S, Meunier D, Nonhoff C, Yunus S, Massart M, Denis O, Woodford N, Hopkins KL, Naas T, Dortet L, Huang TD, Glupczynski Y.Sci Rep. 2017 Aug 307(1):9937.
>The Global Alliance for Infections in Surgery: defining a model for antimicrobial stewardship-results from an international cross-sectional survey. Sartelli M, Labricciosa FM, Barbadoro P, Pagani L, Ansaloni L, Brink AJ, Carlet J, Khanna A, Chichom-Mefire A, Coccolini F, Di Saverio S, May AK, Viale P, Watkins RR, Scudeller L, Abbo LM, Abu-Zidan FM, Adesunkanmi AK, Al-Dahir S, Al-Hasan MN, Alis H, Alves C, Araujo da Silva AR, Augustin G, Bala M, Barie PS, Beltrán MA, Bhangu A, Bouchra B, Brecher SM, Caínzos MA, Camacho-Ortiz A, Catani M, Chandy SJ, Jusoh AC, Cherry-Bukowiec JR, Chiara O, Colak E, Cornely OA, Cui Y, Demetrashvili Z, De Simone B, De Waele JJ, Dhingra S, Di Marzo F, Dogjani A, Dorj G, Dortet L, Duane TM, Elmangory MM, Enani MA, Ferrada P, Esteban Foianini J, Gachabayov M, Gandhi C, Ghnnam WM, Giamarellou H, Gkiokas G, Gomi H, Goranovic T, Griffiths EA, Guerra Gronerth RI, Haidamus Monteiro JC, Hardcastle TC, Hecker A, Hodonou AM, Ioannidis O, Isik A, Iskandar KA, Kafil HS, Kanj SS, Kaplan LJ, Kapoor G, Karamarkovic AR, Kenig J, Kerschaever I, Khamis F, Khokha V, Kiguba R, Kim HB, Ko WC, Koike K, Kozlovska I, Kumar A, Lagunes L, Latifi R, Lee JG, Lee YR, Leppäniemi A, Li Y, Liang SY, Lowman W, Machain GM, Maegele M, Major P, Malama S, Manzano-Nunez R, Marinis A, Martinez Casas I, Marwah S, et al.World J Emerg Surg. 2017 Aug 112:34.
>Beta-lactamase database (BLDB) - structure and function. Naas T, Oueslati S, Bonnin RA, Dabos ML, Zavala A, Dortet L, Retailleau P, Iorga BI.J Enzyme Inhib Med Chem. 2017 Dec32(1):917-919
>OXA-244-Producing Escherichia coli Isolates, a Challenge for Clinical Microbiology Laboratories. Hoyos-Mallecot Y, Naas T, Bonnin RA, Patino R, Glaser P, Fortineau N, Dortet L.Antimicrob Agents Chemother. 2017 Aug 2461(9):e00818-17.
>Comparison of Two Phenotypic Algorithms To Detect Carbapenemase-Producing Enterobacteriaceae. Dortet L, Bernabeu S, Gonzalez C, Naas T.Antimicrob Agents Chemother. 2017 Jul 2561(8):e00796-17.
>MCR-1 and OXA-48 In Vivo Acquisition in KPC-Producing Escherichia coli after Colistin Treatment. Beyrouthy R, Robin F, Lessene A, Lacombat I, Dortet L, Naas T, Ponties V, Bonnet R.Antimicrob Agents Chemother. 2017 Jul 2561(8):e02540-16.
>First report of NDM-1-producing clinical isolate of Leclercia adecarboxylata in Spain. Riazzo C, López-Cerero L, Rojo-Martín MD, Hoyos-Mallecot Y, Fernández-Cuenca F, Martín-Ruíz JL, Pascual-Hernández Á, Naas T, Navarro-Marí JM.Diagn Microbiol Infect Dis. 2017 Jul88(3):268-270.
>Draft Genome Sequence of NDM-1-Producing Leclercia adecarboxylata. Hoyos-Mallecot Y, Rojo-Martín MD, Bonnin RA, Creton E, Navarro Marí JM, Naas T.Genome Announc. 2017 Apr 275(17):e00135-17.
>Performance of the Xpert(®) Carba-R v2 in the daily workflow of a hygiene unit in a country with a low prevalence of carbapenemase-producing Enterobacteriaceae. Hoyos-Mallecot Y, Ouzani S, Dortet L, Fortineau N, Naas T.Int J Antimicrob Agents. 2017 Jun49(6):774-777.
>Development and Validation of a Lateral Flow Immunoassay for Rapid Detection of NDM-Producing Enterobacteriaceae. Boutal H, Naas T, Devilliers K, Oueslati S, Dortet L, Bernabeu S, Simon S, Volland H.J Clin Microbiol. 2017 Jul55(7):2018-2029.
>Prospective evaluation of the OKN K-SeT assay, a new multiplex immunochromatographic test for the rapid detection of OXA-48-like, KPC and NDM carbapenemases. Glupczynski Y, Jousset A, Evrard S, Bonnin RA, Huang TD, Dortet L, Bogaerts P, Naas T.J Antimicrob Chemother. 2017 Jul 172(7):1955-1960.
>First report of OXA-232-producing Klebsiella pneumoniae strains in Tunisia. Lahlaoui H, Bonnin RA, Moussa MB, Khelifa ABH, Naas T.Diagn Microbiol Infect Dis. 2017 Jun88(2):195-197.
>Evaluation of the β-CARBA™ test, a colorimetric test for the rapid detection of carbapenemase activity in Gram-negative bacilli. Bernabeu S, Dortet L, Naas T.J Antimicrob Chemother. 2017 Jun 172(6):1646-1658.
>Promoter characterization and expression of the blaKPC-2 gene in Escherichia coli, Pseudomonas aeruginosa and Acinetobacter baumannii. Girlich D, Bonnin RA, Jousset A, Naas T.J Antimicrob Chemother. 2017 Jun 172(6):1597-1601.
>Trends in carbapenemase-producing Enterobacteriaceae, France, 2012 to 2014. Dortet L, Cuzon G, Ponties V, Nordmann P.Euro Surveill. 2017 Feb 922(6):30461.
>Retrospective and prospective evaluation of the Carbapenem inactivation method for the detection of carbapenemase-producing Enterobacteriaceae. Gauthier L, Bonnin RA, Dortet L, Naas T.PLoS One. 2017 Feb 312(2):e0170769.
>Multidrug resistant bacteria and emerging antibiotic resistance traits. B. Jousset A, Dortet L, Naas T. Rev Prat. 2017 Feb67(2):211-217.
>Noncarbapenemase OXA-48 Variants (OXA-163 and OXA-405) Falsely Detected as Carbapenemases by the β Carba Test. Dortet L, Naas T.J Clin Microbiol. 2017 Feb55(2):654-655.
>Characterization of BRP(MBL), the Bleomycin Resistance Protein Associated with the Carbapenemase NDM. Dortet L, Girlich D, Virlouvet AL, Poirel L, Nordmann P, Iorga BI, Naas T.Antimicrob Agents Chemother. 2017 Feb 2361(3):e02413-16.
>Detection of GES-5 Carbapenemase in Klebsiella pneumoniae, a Newcomer in France. Bonnin RA, Jousset AB, Urvoy N, Gauthier L, Tlili L, Creton E, Cotellon G, Arthur F, Dortet L, Naas T.Antimicrob Agents Chemother. 2017 Feb 2361(3):e02263-16.
>Chromosome-Encoded Broad-Spectrum Ambler Class A β-Lactamase RUB-1 from Serratia rubidaea. Bonnin RA, Didi J, Ergani A, Lima S, Naas T.Antimicrob Agents Chemother. 2017 Jan 2461(2):e01908-16.
>Chromosomal Amplification of the blaOXA-58 Carbapenemase Gene in a Proteus mirabilis Clinical Isolate. Girlich D, Bonnin RA, Bogaerts P, De Laveleye M, Huang DT, Dortet L, Glaser P, Glupczynski Y, Naas T.Antimicrob Agents Chemother. 2017 Jan 2461(2):e01697-16.